Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New thinner sheath could make heart procedures safer for small arteries

NCT ID NCT07410364

Disease control Sponsor: Cai gaojun, MD Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a thinner tube (6-French Glidesheath Slender) can make heart procedures safer for people with small wrist arteries. About 594 adults with coronary artery disease will be randomly assigned to get the standard tube or the thinner one through a wrist access point. The main goal is to see if the thinner tube reduces the chance of the wrist artery getting blocked after the procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
6-French Glidesheath Slender sheath (a thinner tube used during heart catheter procedures)
What this could lead to
If successful, this could make heart procedures safer and more comfortable for people with small wrist arteries, lowering the risk of artery blockage afterward.
What could go wrong
This is a single-center study with 594 participants, so results may not apply to all patients. The thinner sheath might still cause complications or be harder to use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 594 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 85 years * Palpable pulses in both the distal radial artery and conventional radial artery * All patients signed informed consent forms prior to procedure Exclusion Criteria: * Ultrasound assessment of the distal radial artery diameter ≥2.0mm or \<1.0mm * Height ≥185.0cm * Patients with acute ST-segment elevation myocardial infarction, cardiogenic shock, or hemodynamic instability * Contraindications for puncture of the distal radial artery * Patients with Raynaud's syndrome * Patients with coagulation disorders or hematologic diseases * Patients currently enrolled in other clinical studies

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Arterial Occlusive Diseases coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary artery disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Changzhou Wujin People's Hospital

    RECRUITING

    Changzhou, Jiangsu, 213017, China

  • Wujin Hospital Affiliated with Jiangsu University.

    RECRUITING

    Changzhou, Jiangsu, 213017, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.